{"id":"ofloxacine","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Achilles tendinitis","Agranulocytosis","Anemia","Bradycardia","Congenital long QT syndrome","Dehydration","Diabetes mellitus","Disease of liver","Drug-induced hepatitis","Epilepsy","Hallucinations","Hepatic failure","Hypokalemia","Impaired renal function disorder","Kidney disease","Leukopenia","Lowered convulsive threshold","Myasthenia gravis","Myocardial ischemia","Pancytopenia","Peripheral nerve disease","Prolonged QT interval","Pseudomembranous enterocolitis","Rhabdomyolysis","Severe Cerebral Arteriosclerosis","Shoulder Tendonitis","Superimposed infection","Tendinitis","Thrombocytopenic disorder","Torsades de pointes","Transplant of kidney","Transplant of lung","Transplantation of heart","Traumatic rupture of tendon","Tremors","Viral ear infection"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL4","moleculeType":"Small molecule","molecularWeight":"361.37"},"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Gamma-aminobutyric acid receptor subunit alpha-2, Histamine H3 receptor, Muscarinic acetylcholine receptor M1"},"_scrapedAt":"2026-03-28T01:23:55.142Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Abdominal abscess","diseaseId":"abdominal-abscess","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute Moraxella catarrhalis bronchitis","diseaseId":"acute-moraxella-catarrhalis-bronchitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute bacterial bronchitis","diseaseId":"acute-bacterial-bronchitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute bacterial peritonitis","diseaseId":"acute-bacterial-peritonitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute bacterial sinusitis","diseaseId":"acute-bacterial-sinusitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute exacerbation of chronic bronchitis","diseaseId":"acute-exacerbation-of-chronic-bronchitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute gonococcal cervicitis","diseaseId":"acute-gonococcal-cervicitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute gonococcal endometritis","diseaseId":"acute-gonococcal-endometritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute gonococcal urethritis","diseaseId":"acute-gonococcal-urethritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute maxillary sinusitis","diseaseId":"acute-maxillary-sinusitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute osteomyelitis","diseaseId":"acute-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Anthrax","diseaseId":"anthrax","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial Corneal Ulcer Infection","diseaseId":"bacterial-corneal-ulcer-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial conjunctivitis","diseaseId":"bacterial-conjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial infection due to Klebsiella pneumoniae","diseaseId":"bacterial-infection-due-to-klebsiella-pneumoniae","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial pneumonia","diseaseId":"bacterial-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bacterial urinary infection","diseaseId":"bacterial-urinary-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Bronchitis","diseaseId":"bronchitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chancroid","diseaseId":"chancroid","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chlamydia Cervicitis","diseaseId":"chlamydia-cervicitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chlamydial pelvic inflammatory disease","diseaseId":"chlamydial-pelvic-inflammatory-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chlamydial pneumonia","diseaseId":"chlamydial-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chronic Bacterial Prostatitis","diseaseId":"chronic-bacterial-prostatitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chronic Enterococcus faecalis Prostatitis","diseaseId":"chronic-enterococcus-faecalis-prostatitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chronic Escherichia coli Prostatitis","diseaseId":"chronic-escherichia-coli-prostatitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chronic Staphylococcus epidermidis Prostatitis","diseaseId":"chronic-staphylococcus-epidermidis-prostatitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chronic tubotympanic suppurative otitis media","diseaseId":"chronic-tubotympanic-suppurative-otitis-media","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Citrobacter Complicated UTI","diseaseId":"citrobacter-complicated-uti","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Citrobacter Cystitis","diseaseId":"citrobacter-cystitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Citrobacter Urinary Tract Infection","diseaseId":"citrobacter-urinary-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Colorectal Surgery Infection Prevention","diseaseId":"colorectal-surgery-infection-prevention","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated Bacterial Peritonitis","diseaseId":"complicated-bacterial-peritonitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated Bacteroides Peritonitis","diseaseId":"complicated-bacteroides-peritonitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated E. Coli Peritonitis","diseaseId":"complicated-e.-coli-peritonitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated Klebsiella Peritonitis","diseaseId":"complicated-klebsiella-peritonitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated Proteus UTI","diseaseId":"complicated-proteus-uti","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated Skin and Skin Structure Enterococcus Faecalis Infection","diseaseId":"complicated-skin-and-skin-structure-enterococcus-faecalis-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated Skin and Skin Structure Infection","diseaseId":"complicated-skin-and-skin-structure-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated Skin and Skin Structure Proteus Infection","diseaseId":"complicated-skin-and-skin-structure-proteus-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated Skin and Skin Structure Staphylococcus Aureus Infection","diseaseId":"complicated-skin-and-skin-structure-staphylococcus-aureus-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated Skin and Skin Structure Streptococcus Pyogenes Infection","diseaseId":"complicated-skin-and-skin-structure-streptococcus-pyogenes-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated UTI with Pseudomonas Aeruginosa","diseaseId":"complicated-uti-with-pseudomonas-aeruginosa","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Complicated Urinary Tract Infections","diseaseId":"complicated-urinary-tract-infections","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Cystitis","diseaseId":"cystitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Diarrhea due to E. Coli","diseaseId":"diarrhea-due-to-e.-coli","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"E. Coli Cystitis","diseaseId":"e.-coli-cystitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"E. Coli Pyelonephritis","diseaseId":"e.-coli-pyelonephritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Enteric campylobacteriosis","diseaseId":"enteric-campylobacteriosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Enterobacter Cystitis","diseaseId":"enterobacter-cystitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Enterobacter Osteomyelitis","diseaseId":"enterobacter-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Enterobacter Pneumonia","diseaseId":"enterobacter-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"EnterobacterJoint Infection","diseaseId":"enterobacterjoint-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Enterococcus Complicated UTI","diseaseId":"enterococcus-complicated-uti","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Enterococcus Urinary Tract Infection","diseaseId":"enterococcus-urinary-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Escherichia coli urinary tract infection","diseaseId":"escherichia-coli-urinary-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Female genital tract infection","diseaseId":"female-genital-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gonorrhea","diseaseId":"gonorrhea","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gonorrhea of rectum","diseaseId":"gonorrhea-of-rectum","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gram-Negative Aerobic Bacillary Pneumonia","diseaseId":"gram-negative-aerobic-bacillary-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Haemophilus Influenzae Bronchitis","diseaseId":"haemophilus-influenzae-bronchitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Haemophilus Influenzae Chronic Bronchitis","diseaseId":"haemophilus-influenzae-chronic-bronchitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Haemophilus Parainfluenzae Bronchitis","diseaseId":"haemophilus-parainfluenzae-bronchitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Haemophilus Parainfluenzae Pneumonia","diseaseId":"haemophilus-parainfluenzae-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Haemophilus influenzae pneumonia","diseaseId":"haemophilus-influenzae-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection due to Enterobacteriaceae","diseaseId":"infection-due-to-enterobacteriaceae","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection due to Escherichia coli","diseaseId":"infection-due-to-escherichia-coli","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection due to Pseudomonas aeruginosa","diseaseId":"infection-due-to-pseudomonas-aeruginosa","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection due to Staphylococcus aureus","diseaseId":"infection-due-to-staphylococcus-aureus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection of bone","diseaseId":"infection-of-bone","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection of skin AND/OR subcutaneous tissue","diseaseId":"infection-of-skin-and/or-subcutaneous-tissue","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infectious diarrheal disease","diseaseId":"infectious-diarrheal-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infectious disease of abdomen","diseaseId":"infectious-disease-of-abdomen","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infectious disorder of joint","diseaseId":"infectious-disorder-of-joint","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infective cystitis","diseaseId":"infective-cystitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infective otitis externa","diseaseId":"infective-otitis-externa","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infective otitis media","diseaseId":"infective-otitis-media","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Klebsiella Nosocomial Pneumonia","diseaseId":"klebsiella-nosocomial-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Klebsiella cystitis","diseaseId":"klebsiella-cystitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Legionella Pneumophila Pneumonia","diseaseId":"legionella-pneumophila-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Lower respiratory tract infection","diseaseId":"lower-respiratory-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Malignant otitis externa due to Pseudomonas aeruginosa","diseaseId":"malignant-otitis-externa-due-to-pseudomonas-aeruginosa","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Mixed Gonococcal and Chlamydia Infection of the Cervix","diseaseId":"mixed-gonococcal-and-chlamydia-infection-of-the-cervix","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Mixed Gonococcal and Chlamydia Infection of the Urethra","diseaseId":"mixed-gonococcal-and-chlamydia-infection-of-the-urethra","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Moraxella Catarrhalis Chronic Bronchitis","diseaseId":"moraxella-catarrhalis-chronic-bronchitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Moraxella Catarrhalis Pneumonia","diseaseId":"moraxella-catarrhalis-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Morganella Morganii Urinary Tract Infection","diseaseId":"morganella-morganii-urinary-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nongonococcal urethritis","diseaseId":"nongonococcal-urethritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nosocomial Pneumonia due to Escherichia Coli","diseaseId":"nosocomial-pneumonia-due-to-escherichia-coli","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nosocomial Pneumonia due to Haemophilus Influenzae","diseaseId":"nosocomial-pneumonia-due-to-haemophilus-influenzae","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nosocomial Pneumonia due to Klebsiella Pneumoniae","diseaseId":"nosocomial-pneumonia-due-to-klebsiella-pneumoniae","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nosocomial Pneumonia due to Methicillin-Sensitive Staphylococcus Aureus","diseaseId":"nosocomial-pneumonia-due-to-methicillin-sensitive-staphylococcus-aureus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nosocomial Pneumonia due to Serratia Marcescens","diseaseId":"nosocomial-pneumonia-due-to-serratia-marcescens","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nosocomial Pneumonia due to Streptococcus Pneumoniae","diseaseId":"nosocomial-pneumonia-due-to-streptococcus-pneumoniae","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nosocomial pneumonia","diseaseId":"nosocomial-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Otitis externa","diseaseId":"otitis-externa","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pelvic Inflammatory Disease with Neisseria Gonorrhea","diseaseId":"pelvic-inflammatory-disease-with-neisseria-gonorrhea","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumococcal pneumonia","diseaseId":"pneumococcal-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumonia","diseaseId":"pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumonia due to Escherichia coli","diseaseId":"pneumonia-due-to-escherichia-coli","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumonia due to Mycoplasma pneumoniae","diseaseId":"pneumonia-due-to-mycoplasma-pneumoniae","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumonia due to Pseudomonas","diseaseId":"pneumonia-due-to-pseudomonas","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumonia due to Streptococcus","diseaseId":"pneumonia-due-to-streptococcus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Postoperative infection","diseaseId":"postoperative-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Prostatitis","diseaseId":"prostatitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Proteus Cystitis","diseaseId":"proteus-cystitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Proteus Prostatitis","diseaseId":"proteus-prostatitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Proteus pneumonia","diseaseId":"proteus-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Proteus urinary tract infection","diseaseId":"proteus-urinary-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Providencia Urinary Tract Infection","diseaseId":"providencia-urinary-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pseudomonas Aeruginosa Cystitis","diseaseId":"pseudomonas-aeruginosa-cystitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pseudomonas Aeruginosa Joint Infection","diseaseId":"pseudomonas-aeruginosa-joint-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pseudomonas Aeruginosa Osteomyelitis","diseaseId":"pseudomonas-aeruginosa-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pseudomonas Aeruginosa Urinary Tract Infection","diseaseId":"pseudomonas-aeruginosa-urinary-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pyelonephritis","diseaseId":"pyelonephritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Rhinoscleroma","diseaseId":"rhinoscleroma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Septicemia due to Escherichia coli","diseaseId":"septicemia-due-to-escherichia-coli","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Serratia Joint Infection","diseaseId":"serratia-joint-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Serratia Osteomyelitis","diseaseId":"serratia-osteomyelitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Serratia Urinary Tract Infection","diseaseId":"serratia-urinary-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Shigellosis","diseaseId":"shigellosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Skin and Skin Structure Citrobacter Infection","diseaseId":"skin-and-skin-structure-citrobacter-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Skin and Skin Structure Morganella Morganii Infection","diseaseId":"skin-and-skin-structure-morganella-morganii-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Skin and Skin Structure Proteus Infection","diseaseId":"skin-and-skin-structure-proteus-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Skin and Skin Structure Providencia Infection","diseaseId":"skin-and-skin-structure-providencia-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Skin and Skin Structure Pseudomonas Aeruginosa Infection","diseaseId":"skin-and-skin-structure-pseudomonas-aeruginosa-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Skin and Skin Structure Serratia Infection","diseaseId":"skin-and-skin-structure-serratia-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Staphylococcal pneumonia","diseaseId":"staphylococcal-pneumonia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Staphylococcus Aureus Bronchitis","diseaseId":"staphylococcus-aureus-bronchitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Staphylococcus Aureus Otitis Externa","diseaseId":"staphylococcus-aureus-otitis-externa","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Staphylococcus Cystitis","diseaseId":"staphylococcus-cystitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Staphylococcus Epidermidis Skin and Skin Structure Infection","diseaseId":"staphylococcus-epidermidis-skin-and-skin-structure-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Staphylococcus Epidermidis Urinary Tract Infection","diseaseId":"staphylococcus-epidermidis-urinary-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Staphylococcus Saprophyticus Urinary Tract Infection","diseaseId":"staphylococcus-saprophyticus-urinary-tract-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Streptococcus Pneumoniae Bronchitis","diseaseId":"streptococcus-pneumoniae-bronchitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Streptococcus Pneumoniae Chronic Bronchitis","diseaseId":"streptococcus-pneumoniae-chronic-bronchitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Streptococcus pyogenes infection","diseaseId":"streptococcus-pyogenes-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Synergy for Nosocomial Pneumonia due to Pseudomonas Aeruginosa","diseaseId":"synergy-for-nosocomial-pneumonia-due-to-pseudomonas-aeruginosa","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Typhoid fever","diseaseId":"typhoid-fever","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Urethritis due to Chlamydia trachomatis","diseaseId":"urethritis-due-to-chlamydia-trachomatis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Urinary tract infection caused by Klebsiella","diseaseId":"urinary-tract-infection-caused-by-klebsiella","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Urinary tract infectious disease","diseaseId":"urinary-tract-infectious-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Vaginal Hysterectomy Infection Prevention","diseaseId":"vaginal-hysterectomy-infection-prevention","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06568484","phase":"PHASE2, PHASE3","title":"Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-07","conditions":"Tuberculosis, Latent","enrollment":2530},{"nctId":"NCT07487142","phase":"PHASE3","title":"Prevalence of Asymptomatic H Pylori Infection Among Patients Undergoing PCI and Impact of Its Eradication on Occurrence of GIT Symptoms and Bleeding\"","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2024-06-10","conditions":"H Pylori Infection","enrollment":121},{"nctId":"NCT05444439","phase":"NA","title":"Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy","status":"COMPLETED","sponsor":"Assiut University","startDate":"2024-01-20","conditions":"H Pylori Infection","enrollment":100},{"nctId":"NCT07179159","phase":"NA","title":"Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication: A Multicentre, Non-Inferiority Randomized Controlled Trial","status":"RECRUITING","sponsor":"Yanqing Li","startDate":"2025-09-09","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":372},{"nctId":"NCT07454772","phase":"PHASE1, PHASE2","title":"Antibiotics vs Corticosteroids in Treatment of Granulomatous Lobular Mastitis","status":"NOT_YET_RECRUITING","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2026-03-15","conditions":"Granulomatous Mastitis","enrollment":72},{"nctId":"NCT07455448","phase":"","title":"Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-03","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":7228},{"nctId":"NCT06889701","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants","status":"RECRUITING","sponsor":"TenNor Therapeutics Inc.","startDate":"2025-04-03","conditions":"Periprosthetic Joint Infection (PJI)","enrollment":33},{"nctId":"NCT06494072","phase":"PHASE4","title":"Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2024-08-22","conditions":"Community Acquired Pneumonia in Children","enrollment":236},{"nctId":"NCT05398679","phase":"PHASE4","title":"Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis","status":"RECRUITING","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2022-08-17","conditions":"Endocarditis Infective","enrollment":360},{"nctId":"NCT02701608","phase":"PHASE3","title":"Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2016-02-29","conditions":"Infective Endocarditis","enrollment":162},{"nctId":"NCT07405684","phase":"PHASE4","title":"Fecal Molecular Susceptibility-guided Hp First-line Therapy","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-02-28","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":544},{"nctId":"NCT07405697","phase":"PHASE4","title":"Fecal Molecular Susceptibility-guided Hp Rescue Therapy","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-02-28","conditions":"Helicobacter Pylori Infection","enrollment":290},{"nctId":"NCT03511118","phase":"","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","status":"RECRUITING","sponsor":"Duke University","startDate":"2018-10-04","conditions":"Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI","enrollment":1600},{"nctId":"NCT06537609","phase":"NA","title":"A Platform Trial for Gram Negative Bloodstream Infections","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2024-04-24","conditions":"Gram-negative Bacteremia","enrollment":2500},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT04371445","phase":"PHASE4","title":"Dextenza in the Post-op Management of Vitreoretinal Surgeries","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2020-06-01","conditions":"Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain","enrollment":30},{"nctId":"NCT06498414","phase":"PHASE2, PHASE3","title":"Shorter and Safer Treatment Regimens for Latent TB","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2025-06-10","conditions":"Tuberculosis Infection, Latent","enrollment":1800},{"nctId":"NCT07069582","phase":"PHASE1","title":"Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women","status":"NOT_YET_RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2026-04-01","conditions":"Tuberculosis Infection, Healthy Volunteer, Breastfeeding","enrollment":60},{"nctId":"NCT06810583","phase":"PHASE1","title":"A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2025-05-22","conditions":"Leukemia, Acute Myeloid Leukemia, Lymphoblastic Leukemia in Children","enrollment":29},{"nctId":"NCT07170800","phase":"PHASE2","title":"A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets","status":"RECRUITING","sponsor":"WestVac Biopharma Co., Ltd.","startDate":"2025-09-19","conditions":"Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis","enrollment":60},{"nctId":"NCT07246967","phase":"NA","title":"Antibiotic Prophylaxis for Ureteroscopy With a Negative Pressure Suction Sheath","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-02","conditions":"Urolithiasis, Antibiotics","enrollment":500},{"nctId":"NCT07355907","phase":"NA","title":"Preoperative Prophylactic Fosfomycin Trometamol Versus 5-day Levofloxacin in Prevention of Postpercutaneous Nephrolithotomy Infectious Complications and Sepsis.","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-01-01","conditions":"Calculi, Renal, PCNL, Infectious Complications","enrollment":210},{"nctId":"NCT07344506","phase":"PHASE4","title":"CURE-H. Pylori: A Trial on the Combination of Anti-Ulcerants and Levofloxacin-Based Therapy for Helicobacter Pylori Eradication","status":"RECRUITING","sponsor":"Dow University of Health Sciences","startDate":"2025-05-01","conditions":"H. Pylori Gastrointestinal Disease, H.Pylori Infection, H.Pylori Eradication Rate","enrollment":942},{"nctId":"NCT05074147","phase":"PHASE3","title":"Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis (CHRONOS-2)","status":"WITHDRAWN","sponsor":"Tourcoing Hospital","startDate":"2022-05-01","conditions":"Osteomyelitis - Foot","enrollment":""},{"nctId":"NCT07332325","phase":"PHASE3","title":"STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2026-04","conditions":"Sepsis, Tuberculosis","enrollment":344},{"nctId":"NCT07320534","phase":"PHASE4","title":"Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase","status":"NOT_YET_RECRUITING","sponsor":"Gadjah Mada University","startDate":"2026-01-01","conditions":"Neutropenic Fever, Acute Lymphoblastic Leukemia","enrollment":124},{"nctId":"NCT04951986","phase":"PHASE3","title":"Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cape Town","startDate":"2021-08-11","conditions":"Disseminated Tuberculosis, HIV","enrollment":732},{"nctId":"NCT03594149","phase":"PHASE3","title":"Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients","status":"COMPLETED","sponsor":"Centre Henri Becquerel","startDate":"2018-07-18","conditions":"Myelodysplastic Syndromes, Acute Myeloid Leukemia","enrollment":60},{"nctId":"NCT05079620","phase":"PHASE4","title":"Early Antibiotics After Aspiration in ICU Patients","status":"TERMINATED","sponsor":"UConn Health","startDate":"2021-11-30","conditions":"Aspiration, Aspiration Pneumonia","enrollment":5},{"nctId":"NCT05816070","phase":"PHASE2","title":"Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis","status":"COMPLETED","sponsor":"IVIEW Therapeutics Inc.","startDate":"2023-01-05","conditions":"Acute Bacterial Conjunctivitis","enrollment":129},{"nctId":"NCT00042289","phase":"","title":"Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2003-06-09","conditions":"HIV Infections","enrollment":1578},{"nctId":"NCT07240077","phase":"PHASE4","title":"Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia","status":"NOT_YET_RECRUITING","sponsor":"Mahidol University","startDate":"2026-01-01","conditions":"Bacteremia, Streptococcus Infection","enrollment":165},{"nctId":"NCT07229755","phase":"PHASE2, PHASE3","title":"Comparison Between Effect of Empirical Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy in Children With Pyuria","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-07-01","conditions":"Urinary Tract Infection (Diagnosis)","enrollment":140},{"nctId":"NCT04518228","phase":"","title":"Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-09-01","conditions":"HIV Infections, Tuberculosis","enrollment":205},{"nctId":"NCT03933631","phase":"PHASE3","title":"Pilocarpine Use After Kahook Goniotomy","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2019-05-01","conditions":"Glaucoma","enrollment":142},{"nctId":"NCT03850379","phase":"PHASE2","title":"Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2018-03-14","conditions":"Prophylaxis, Stem Cell Transplant Complications","enrollment":308},{"nctId":"NCT07198685","phase":"NA","title":"6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province","status":"NOT_YET_RECRUITING","sponsor":"Wuhan Pulmonary Hospital","startDate":"2025-09-30","conditions":"Treat to Target, Treatment Duration","enrollment":52},{"nctId":"NCT06797544","phase":"PHASE2","title":"Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis","status":"RECRUITING","sponsor":"Hayder Adnan Fawzi","startDate":"2025-02-09","conditions":"Cutaneous Leishmaniasis","enrollment":40},{"nctId":"NCT05332444","phase":"PHASE4","title":"Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2022-04-11","conditions":"Helicobacter Pylori Infection","enrollment":450},{"nctId":"NCT07150286","phase":"NA","title":"Helicobacter Pylori Eradication Therapy for Immune Thrombocytopenia (ITP) Patients in Iraq","status":"COMPLETED","sponsor":"Al-Mustansiriyah University","startDate":"2024-09-01","conditions":"Immune Thrombocytopenic Purpura, HELICOBACTER PYLORI INFECTIONS","enrollment":100},{"nctId":"NCT06649721","phase":"PHASE3","title":"Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort","status":"ACTIVE_NOT_RECRUITING","sponsor":"Huashan Hospital","startDate":"2024-11-27","conditions":"Drug-resistant Tuberculosis, Pulmonary Tuberculosis, Rifampin-resistant Tuberculosis","enrollment":120},{"nctId":"NCT07150065","phase":"PHASE2","title":"Efficacy of Levofloxacin Versus Ciprofloxacin in the Treatment of Childhood Typhoid Fever","status":"COMPLETED","sponsor":"Avicenna Medical College Lahore","startDate":"2025-02-07","conditions":"Typhoid, Fever","enrollment":360},{"nctId":"NCT04332848","phase":"PHASE4","title":"Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2020-07-28","conditions":"Helicobacter Pylori Infection","enrollment":360},{"nctId":"NCT05977868","phase":"PHASE4","title":"Comparing Oral Versus Parenteral Antimicrobial Therapy","status":"TERMINATED","sponsor":"West Virginia University","startDate":"2023-08-04","conditions":"Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection","enrollment":94},{"nctId":"NCT07130253","phase":"NA","title":"Efficacy of Vonoprazan-based Rescue Therapy for H. Pylori Eradication","status":"NOT_YET_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2025-08-18","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":220},{"nctId":"NCT07126639","phase":"NA","title":"A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis","status":"NOT_YET_RECRUITING","sponsor":"Wuhan Pulmonary Hospital","startDate":"2025-09-01","conditions":"Efficacy and Safety","enrollment":200},{"nctId":"NCT04502095","phase":"PHASE4","title":"Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2020-09-02","conditions":"Bladder Carcinoma, Refractory Bladder Carcinoma, Urinary Tract Infection","enrollment":89},{"nctId":"NCT03935828","phase":"PHASE2","title":"Effect of Topical Sinonasal Antibiotics","status":"WITHDRAWN","sponsor":"United States Naval Medical Center, San Diego","startDate":"2019-06","conditions":"Chronic Rhinosinusitis (Diagnosis), Antibiotic Side Effect","enrollment":""},{"nctId":"NCT06209047","phase":"PHASE4","title":"Bronchoscopic Levofloxacin, Gentamicin, or Sham for Acute Exacerbation of Bronchiectasis","status":"RECRUITING","sponsor":"Assiut University","startDate":"2023-10-15","conditions":"Bronchiectasis With Acute Exacerbation","enrollment":315},{"nctId":"NCT07040839","phase":"PHASE4","title":"Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Rehman Medical Institute - RMI","startDate":"2025-07","conditions":"H Pylori","enrollment":128},{"nctId":"NCT03479736","phase":"","title":"A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-11-20","conditions":"Retinal Detachment, Achilles Tendon, Aneurysm, Dissecting","enrollment":117911},{"nctId":"NCT07021729","phase":"PHASE4","title":"Comparison of Two Treatment Regimens of Helicobacter Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Rehman Medical Institute - RMI","startDate":"2025-12","conditions":"Helicobacter Pylori Infection","enrollment":156},{"nctId":"NCT04496024","phase":"NA","title":"Ofloxacin Concentration-toxicity Relationship in the Elderly","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2020-06-02","conditions":"Ofloxacin, Bone and Joint Infection, Therapeutic Drug Monitoring","enrollment":110},{"nctId":"NCT05739682","phase":"NA","title":"Pain and Microbial Reduction of Antimicrobial Corticosteroid Mixture Versus Cryotherapy in Necrotic Teeth","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-07-01","conditions":"Dental Pulp Necrosis","enrollment":28},{"nctId":"NCT06977347","phase":"NA","title":"Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea","status":"NOT_YET_RECRUITING","sponsor":"CHOSEOK YOON","startDate":"2025-06-15","conditions":"Severe Community-acquired Pneumonia (sCAP)","enrollment":100},{"nctId":"NCT03828201","phase":"PHASE2","title":"Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB","status":"RECRUITING","sponsor":"Boston University","startDate":"2022-06-07","conditions":"Tuberculosis, Multidrug-Resistant","enrollment":220},{"nctId":"NCT05946655","phase":"NA","title":"Diagnostics of Chronic Endometritis in Infertility","status":"COMPLETED","sponsor":"Jagiellonian University","startDate":"2021-04-01","conditions":"Infertility Unexplained, Abnormal Uterine Bleeding, Intrauterine Disorder","enrollment":102},{"nctId":"NCT06915688","phase":"NA","title":"A Study Comparing Doxycycline and Levofloxacin for Treating COPD Exacerbations","status":"NOT_YET_RECRUITING","sponsor":"Amina Aslam","startDate":"2025-04-15","conditions":"COPD","enrollment":188},{"nctId":"NCT05081401","phase":"PHASE3","title":"Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2022-05-23","conditions":"Multidrug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis, Pre-XDR-TB","enrollment":1050},{"nctId":"NCT06081361","phase":"PHASE3","title":"Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Chest Hospital","startDate":"2023-12-22","conditions":"Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis","enrollment":186},{"nctId":"NCT06859450","phase":"PHASE2, PHASE3","title":"Local Antibiotic Delivery for Community Acquired Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Copenhagen Respiratory Research","startDate":"2025-03-04","conditions":"Community Acquired Pneumonia (CAP)","enrollment":36},{"nctId":"NCT04270786","phase":"NA","title":"Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever","status":"RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2020-01-01","conditions":"Safety Issues","enrollment":200},{"nctId":"NCT01710488","phase":"PHASE4","title":"Comparison Between Levofloxacin and Prulifloxacin, in Internal Medicine Patients With Acute Exacerbation of COPD","status":"COMPLETED","sponsor":"Fadoi Foundation, Italy","startDate":"2009-05","conditions":"COPD Exacerbation","enrollment":258},{"nctId":"NCT02754765","phase":"PHASE3","title":"Evaluating Newly Approved Drugs for Multidrug-resistant TB","status":"COMPLETED","sponsor":"Médecins Sans Frontières, France","startDate":"2016-12","conditions":"Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses","enrollment":754},{"nctId":"NCT06787885","phase":"NA","title":"Evaluation of Efficacy and Safety Parameters of Different Antibiotics Regimens for Management of Empyema","status":"RECRUITING","sponsor":"Fayoum University","startDate":"2024-05-01","conditions":"Empyema, Pleural","enrollment":90},{"nctId":"NCT02365623","phase":"PHASE2","title":"An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)","status":"COMPLETED","sponsor":"Janssen Pharmaceutical K.K.","startDate":"2015-02-18","conditions":"Tuberculosis, Multidrug-Resistant","enrollment":6},{"nctId":"NCT06760143","phase":"","title":"Antibiotic Prophylaxis in Lung-Transplant Recipients","status":"COMPLETED","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2024-01-12","conditions":"Lung-transplant Recipients, Antibiotic Prophylaxis","enrollment":90},{"nctId":"NCT06760065","phase":"PHASE3","title":"Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment","status":"NOT_YET_RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-01-15","conditions":"Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education","enrollment":316},{"nctId":"NCT02619994","phase":"PHASE2","title":"Treatment Shortening of MDR-TB Using Existing and New Drugs","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2016-01","conditions":"Tuberculosis, Multidrug-Resistant","enrollment":214},{"nctId":"NCT00677365","phase":"PHASE2","title":"Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients","status":"COMPLETED","sponsor":"Amgen","startDate":"2008-06","conditions":"Cystic Fibrosis (CF)","enrollment":151},{"nctId":"NCT00739648","phase":"PHASE2","title":"A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients","status":"COMPLETED","sponsor":"Amgen","startDate":"2008-10","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":322},{"nctId":"NCT06200779","phase":"PHASE4","title":"Tailored Vs. Empirical Helicobacter Pylori Infection Treatment","status":"NOT_YET_RECRUITING","sponsor":"Manuel Coelho da Rocha","startDate":"2025-09","conditions":"Helicobacter Pylori Infection","enrollment":160},{"nctId":"NCT06741917","phase":"PHASE4","title":"Retrograde Intrarenal Surgery Low Risk Trial","status":"ENROLLING_BY_INVITATION","sponsor":"National Taiwan University Hospital","startDate":"2024-12-04","conditions":"Retrograde Intrarenal Surgery, Renal Stones","enrollment":200},{"nctId":"NCT01180634","phase":"PHASE3","title":"MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis","status":"COMPLETED","sponsor":"Amgen","startDate":"2010-11-04","conditions":"Cystic Fibrosis","enrollment":330},{"nctId":"NCT01270347","phase":"PHASE3","title":"Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients","status":"COMPLETED","sponsor":"Amgen","startDate":"2011-01","conditions":"Cystic Fibrosis","enrollment":282},{"nctId":"NCT00840333","phase":"PHASE1","title":"\"Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients\"","status":"COMPLETED","sponsor":"Amgen","startDate":"2009-04","conditions":"Cystic Fibrosis","enrollment":27},{"nctId":"NCT00752414","phase":"PHASE1","title":"A Phase 1b Study to Evaluate the Safety and PK of MP-376 in Chronic Obstructive Pulmonary Disease (COPD) Patients","status":"COMPLETED","sponsor":"Amgen","startDate":"2008-07","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":21},{"nctId":"NCT00503490","phase":"PHASE1","title":"Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis","status":"COMPLETED","sponsor":"Amgen","startDate":"2007-06","conditions":"Cystic Fibrosis","enrollment":40},{"nctId":"NCT06710977","phase":"EARLY_PHASE1","title":"To Compare the Safety and Efficacy of Intracameral Levofloxacin and Intracameral Cefazolin in Reducing Rates of Endophthalmitis Following Cataract Surgery.","status":"COMPLETED","sponsor":"Tan Tock Seng Hospital","startDate":"2022-01-01","conditions":"Cataract","enrollment":50},{"nctId":"NCT03220074","phase":"PHASE4","title":"Linezolid for Treatment of Nontuberculous Mycobacterial Diseases","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2017-12-15","conditions":"Non-tuberculous Mycobacterial Infections","enrollment":40},{"nctId":"NCT06684626","phase":"PHASE3","title":"The Role of Butirprost® in Combination With Antibiotics in Chronic Bacterial Prostatitis (CBP) Treatment","status":"COMPLETED","sponsor":"Federico II University","startDate":"2024-03-01","conditions":"Prostate Inflammation, Prostate Disease, Chronic Bacterial Prostatitis","enrollment":60},{"nctId":"NCT03867136","phase":"PHASE4","title":"Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)","status":"COMPLETED","sponsor":"Huashan Hospital","startDate":"2020-06-01","conditions":"Multidrug Resistant Tuberculosis","enrollment":354},{"nctId":"NCT06674291","phase":"","title":"Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)","status":"NOT_YET_RECRUITING","sponsor":"Korea Otsuka Pharmaceutical Co., Ltd.","startDate":"2024-11-30","conditions":"Tuberculosis, Multidrug-Resistant","enrollment":222},{"nctId":"NCT06650540","phase":"NA","title":"Levofloxacin Plus Metronidazole Suppositories Versus Levofloxacin Co-administered with Metronidazole Tablets in Chronic Endometritis","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2024-10-22","conditions":"IVF","enrollment":800},{"nctId":"NCT06017479","phase":"PHASE1, PHASE2","title":"Effectiveness of Single Dose Fosfomycin and Single Dose Levofloxacin as Pre-urodynamic Antibiotic for UTI Prevention","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2022-12-30","conditions":"Urological System Complication of Procedure, Urinary Tract Infections","enrollment":126},{"nctId":"NCT05743101","phase":"NA","title":"Safety and Efficacy Study of Levofloxacin Combined With Endovascular Thrombectomy for Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Yi Yang","startDate":"2025-05-01","conditions":"Acute Ischemic Stroke","enrollment":80},{"nctId":"NCT05799326","phase":"NA","title":"Safety and Efficacy of Levofloxacin for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Yi Yang","startDate":"2023-06-30","conditions":"Acute Ischemic Stroke","enrollment":100},{"nctId":"NCT05741905","phase":"NA","title":"Safety and Efficacy of Levofloxacin Combined With Intravenous Thrombolysis for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Yi Yang","startDate":"2023-06-01","conditions":"Acute Ischemic Stroke","enrollment":100},{"nctId":"NCT05893147","phase":"NA","title":"BALANCE+ Vanguard Phase","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2023-08-26","conditions":"Gram-negative Bacteremia","enrollment":174},{"nctId":"NCT06616922","phase":"PHASE2","title":"Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults","status":"COMPLETED","sponsor":"NTC srl","startDate":"2021-11-05","conditions":"Conjunctivitis, Bacterial","enrollment":252},{"nctId":"NCT05302531","phase":"PHASE1","title":"Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome","status":"RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2022-12-09","conditions":"Short Bowel Syndrome, Infection, Bacterial","enrollment":10},{"nctId":"NCT04062201","phase":"PHASE3","title":"Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care","status":"COMPLETED","sponsor":"Wits Health Consortium (Pty) Ltd","startDate":"2019-08-22","conditions":"Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis","enrollment":402},{"nctId":"NCT06571097","phase":"NA","title":"Levofloxacin in the Treatment of Chronic Functional Constipation Associated With PIB(Peristaltic Contraction-Inhibiting Bacterium) Infection","status":"RECRUITING","sponsor":"Haifeng Lan","startDate":"2024-07-01","conditions":"Constipation","enrollment":50},{"nctId":"NCT06526039","phase":"PHASE3","title":"A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB","status":"NOT_YET_RECRUITING","sponsor":"Taipei Medical University WanFang Hospital","startDate":"2024-07","conditions":"Tuberculosis, Pulmonary","enrollment":100},{"nctId":"NCT05867654","phase":"PHASE4","title":"Efficacy of Oral vs IV Antibiotics in the Treatment of Orofacial Osteomyelitis","status":"NOT_YET_RECRUITING","sponsor":"University of Louisville","startDate":"2024-07-31","conditions":"Osteomyelitis of Jaw","enrollment":100},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT03655665","phase":"PHASE4","title":"Does Topical Otic Drop Use at Time of Tympanostomy Tube Surgery Improve Outcomes When no Middle Ear Effusion is Present","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2019-05-16","conditions":"Otitis Media","enrollment":125},{"nctId":"NCT06414707","phase":"PHASE3","title":"Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-10-12","conditions":"Helicobacter Pylori Infection","enrollment":320},{"nctId":"NCT02424461","phase":"PHASE3","title":"Antibiotic Treatment for 7 Days Versus 14 Days in Patients With Acute Male Urinary Tract Infection","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-01-25","conditions":"Acute Male Urinary Tract Infection","enrollment":274},{"nctId":"NCT00720980","phase":"","title":"Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2008-05","conditions":"Granuloma Annulare","enrollment":6}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":87,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_3","status":"active","brandName":"Ofloxacine","genericName":"Ofloxacine","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ofloxacine is a small molecule that inhibits bacterial DNA gyrase, a mechanism that is consistent with its classification as an inhibitor. It has been studied in clinical trials for various conditions, including glaucoma, cataract, renal diseases, urolithiasis, and as an antibiotic.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}